A national, U.S. federally funded study has found that testing a developing fetus’ DNA through chromosomal microarray (CMA) provides more information about potential disorders than does the standard method of prenatal testing, which is to visually examine the chromosomes (karyotyping).
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- New ways sleep-wake patterns are like clockwork
- Unsafe at any speed: Even for driving pros, distractions increase crash risk
- Fever during pregnancy more than doubles the risk of autism or developmental delay
- Scientists unravel role of fusion gene in prostate cancer
- Food fight or romantic dinner? Communication between couples is key to improving men's diets